Free Trial

Cognex Co. (NASDAQ:CGNX) Given Average Rating of "Moderate Buy" by Analysts

Cognex logo with Computer and Technology background

Cognex Co. (NASDAQ:CGNX - Get Free Report) has been given an average recommendation of "Moderate Buy" by the fourteen brokerages that are currently covering the company, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating, six have assigned a buy rating and one has given a strong buy rating to the company. The average 1 year price objective among brokerages that have updated their coverage on the stock in the last year is $39.17.

CGNX has been the subject of several recent analyst reports. Stephens restated an "overweight" rating and issued a $55.00 price target on shares of Cognex in a research note on Wednesday, March 12th. TD Cowen upgraded Cognex from a "hold" rating to a "buy" rating and set a $35.00 price target for the company in a research note on Monday, April 28th. Cowen upgraded Cognex from a "hold" rating to a "buy" rating in a research note on Monday, April 28th. HSBC downgraded Cognex from a "buy" rating to a "hold" rating and set a $33.00 price target for the company. in a research note on Friday, February 21st. Finally, Robert W. Baird dropped their price target on Cognex from $42.00 to $38.00 and set a "neutral" rating for the company in a research note on Tuesday, February 18th.

Read Our Latest Stock Report on Cognex

Cognex Trading Down 0.0%

Cognex stock opened at $31.61 on Wednesday. The firm has a 50 day moving average of $28.12 and a 200 day moving average of $34.48. The firm has a market capitalization of $5.31 billion, a price-to-earnings ratio of 51.82 and a beta of 1.45. Cognex has a 12-month low of $22.67 and a 12-month high of $53.13.

Cognex (NASDAQ:CGNX - Get Free Report) last posted its quarterly earnings results on Wednesday, February 12th. The scientific and technical instruments company reported $0.14 earnings per share for the quarter, missing the consensus estimate of $0.15 by ($0.01). Cognex had a return on equity of 5.65% and a net margin of 11.61%. On average, analysts predict that Cognex will post 0.61 EPS for the current year.

Cognex Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, May 29th. Investors of record on Thursday, May 15th will be given a $0.08 dividend. The ex-dividend date is Thursday, May 15th. This represents a $0.32 dividend on an annualized basis and a yield of 1.01%. Cognex's dividend payout ratio is presently 47.06%.

Insider Buying and Selling

In other Cognex news, EVP Carl Gerst sold 6,803 shares of the stock in a transaction on Monday, February 24th. The stock was sold at an average price of $32.73, for a total value of $222,662.19. Following the sale, the executive vice president now owns 4,566 shares in the company, valued at $149,445.18. This trade represents a 59.84% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 1.60% of the stock is owned by corporate insiders.

Institutional Trading of Cognex

A number of hedge funds and other institutional investors have recently bought and sold shares of CGNX. SBI Securities Co. Ltd. purchased a new stake in Cognex in the fourth quarter worth $29,000. Farther Finance Advisors LLC increased its stake in shares of Cognex by 439.4% during the first quarter. Farther Finance Advisors LLC now owns 971 shares of the scientific and technical instruments company's stock valued at $29,000 after buying an additional 791 shares during the period. SRS Capital Advisors Inc. increased its stake in shares of Cognex by 50.0% during the fourth quarter. SRS Capital Advisors Inc. now owns 885 shares of the scientific and technical instruments company's stock valued at $32,000 after buying an additional 295 shares during the period. GAMMA Investing LLC increased its stake in shares of Cognex by 155.3% during the first quarter. GAMMA Investing LLC now owns 1,062 shares of the scientific and technical instruments company's stock valued at $32,000 after buying an additional 646 shares during the period. Finally, CBIZ Investment Advisory Services LLC increased its stake in shares of Cognex by 129.9% during the fourth quarter. CBIZ Investment Advisory Services LLC now owns 1,007 shares of the scientific and technical instruments company's stock valued at $36,000 after buying an additional 569 shares during the period. Hedge funds and other institutional investors own 88.12% of the company's stock.

Cognex Company Profile

(Get Free Report

Cognex Corporation provides machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, electric vehicle batteries, and e-commerce packages by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.

Featured Stories

Analyst Recommendations for Cognex (NASDAQ:CGNX)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Cognex Right Now?

Before you consider Cognex, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cognex wasn't on the list.

While Cognex currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

7 Nuclear Stocks One Announcement Away from Exploding
3 AI ETFs for Steady Gains in 2025 (Without the Wild Volatility)
Goldman Sachs Warns of 20% Market Drop—Are They Right?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines